Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kiniksa Pharmaceuticals International (KNSA) Prepaid Assets (2021 - 2025)

Kiniksa Pharmaceuticals International (KNSA) has disclosed Prepaid Assets for 5 consecutive years, with $42.6 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Prepaid Assets rose 112.18% year-over-year to $42.6 million, compared with a TTM value of $42.6 million through Dec 2025, up 112.18%, and an annual FY2025 reading of $42.6 million, up 112.18% over the prior year.
  • Prepaid Assets was $42.6 million for Q4 2025 at Kiniksa Pharmaceuticals International, up from $30.3 million in the prior quarter.
  • Across five years, Prepaid Assets topped out at $42.6 million in Q4 2025 and bottomed at $6.6 million in Q4 2021.
  • Average Prepaid Assets over 5 years is $19.0 million, with a median of $14.7 million recorded in 2022.
  • The sharpest move saw Prepaid Assets dropped 11.18% in 2023, then skyrocketed 116.67% in 2024.
  • Year by year, Prepaid Assets stood at $6.6 million in 2021, then surged by 60.02% to $10.5 million in 2022, then skyrocketed by 66.44% to $17.5 million in 2023, then increased by 14.52% to $20.1 million in 2024, then soared by 112.18% to $42.6 million in 2025.
  • Business Quant data shows Prepaid Assets for KNSA at $42.6 million in Q4 2025, $30.3 million in Q3 2025, and $32.4 million in Q2 2025.